HEMOLYSATE-MEDIATED PLATELET AGGREGATION: AN ADDITIONAL RISK MECHANISM CONTRIBUTING TO THROMBOSIS OF CONTINUOUS FLOW VENTRICULAR ASSIST DEVICES

Despite the clinical success and growth in the utilization of continuous flow ventricular assist devices (cfVADs) for the treatment of advanced heart failure, hemolysis and thrombosis remain major limitations. Inadequate and/or ineffective anticoagulation regimens, combined with high pump speed and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Perfusion
Main Authors: Tran, Phat L., Pietropaolo, Maria-Grazia, Valerio, Lorenzo, Brengle, William, Wong, Raymond K., Kazui, Toshinobu, Khalpey, Zain I., Redaelli, Alberto, Sheriff, Jawaad, Bluestein, Danny, Slepian, Marvin J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4874907/
https://ncbi.nlm.nih.gov/pubmed/26590166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0267659115615206
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados